Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Genprex, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 27 | 27 | 0 |
| Shares | 93.5K | 299.4K | +205.9K (+220.2%) |
| Value | $169.0K | $154.9K | −$14.0K (−8.3%) |
New holders (6)
Institutions that held Genprex, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Fiduciary Trust Co | 78,104 | $40.5K | 0.00% |
| HRT Financial LP | 72,061 | $37.0K | 0.00% |
| Engineers Gate Manager LP | 20,885 | $10.8K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,847 | $1.48K | 0.00% |
| Barclays PLC | 1,578 | $819 | 0.00% |
| Global Retirement Partners, LLC | 1 | $1 | 0.00% |
Sold out (6)
Institutions that held Genprex, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Manchester Financial Inc | 20,000 | $36.2K |
| FNY Investment Advisers, LLC | 5,000 | $9.00K |
| Cygnus Capital Advisors, LLC | 2,195 | $4.00K |
| Citigroup Inc | 2,039 | $3.69K |
| Sound Income Strategies, LLC | 1,000 | $1.58K |
| Curio Wealth, LLC | 1 | $2 |